JP2015505245A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505245A5 JP2015505245A5 JP2014550413A JP2014550413A JP2015505245A5 JP 2015505245 A5 JP2015505245 A5 JP 2015505245A5 JP 2014550413 A JP2014550413 A JP 2014550413A JP 2014550413 A JP2014550413 A JP 2014550413A JP 2015505245 A5 JP2015505245 A5 JP 2015505245A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- pdgfc
- subject
- rna
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100040681 Platelet-derived growth factor C Human genes 0.000 claims description 71
- 108010017992 platelet-derived growth factor C Proteins 0.000 claims description 71
- 238000000034 method Methods 0.000 claims description 55
- -1 LOC731777 Proteins 0.000 claims description 44
- 239000000523 sample Substances 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 101001044438 Homo sapiens Intraflagellar transport protein 52 homolog Proteins 0.000 claims description 12
- 102100022470 Intraflagellar transport protein 52 homolog Human genes 0.000 claims description 12
- 239000000090 biomarker Substances 0.000 claims description 9
- 101000683584 Homo sapiens Ribosome-binding protein 1 Proteins 0.000 claims description 7
- 101000804821 Homo sapiens WD repeat and SOCS box-containing protein 2 Proteins 0.000 claims description 7
- 102100023542 Ribosome-binding protein 1 Human genes 0.000 claims description 7
- 102100035329 WD repeat and SOCS box-containing protein 2 Human genes 0.000 claims description 7
- 239000012472 biological sample Substances 0.000 claims description 7
- 102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 claims description 6
- 102100036732 Actin, aortic smooth muscle Human genes 0.000 claims description 6
- 102100040149 Adenylyl-sulfate kinase Human genes 0.000 claims description 6
- 102100026609 Aldehyde dehydrogenase family 3 member B1 Human genes 0.000 claims description 6
- 102100021325 Antizyme inhibitor 1 Human genes 0.000 claims description 6
- 102100027154 Butyrophilin subfamily 3 member A3 Human genes 0.000 claims description 6
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 claims description 6
- 102000015792 Cyclin-Dependent Kinase 2 Human genes 0.000 claims description 6
- 102100032049 E3 ubiquitin-protein ligase LRSAM1 Human genes 0.000 claims description 6
- 102100023148 Endoribonuclease YbeY Human genes 0.000 claims description 6
- 102100039621 Epithelial-stromal interaction protein 1 Human genes 0.000 claims description 6
- 206010015150 Erythema Diseases 0.000 claims description 6
- 102100039207 Exportin-T Human genes 0.000 claims description 6
- 102100022112 F-box only protein 30 Human genes 0.000 claims description 6
- 102100029525 F-box only protein 7 Human genes 0.000 claims description 6
- 102000013601 Fanconi Anemia Complementation Group D2 protein Human genes 0.000 claims description 6
- 108010026653 Fanconi Anemia Complementation Group D2 protein Proteins 0.000 claims description 6
- 102100035340 Guanine nucleotide-binding protein subunit beta-4 Human genes 0.000 claims description 6
- 102100022191 Hemogen Human genes 0.000 claims description 6
- 102100028902 Hermansky-Pudlak syndrome 1 protein Human genes 0.000 claims description 6
- 101000929319 Homo sapiens Actin, aortic smooth muscle Proteins 0.000 claims description 6
- 101000717973 Homo sapiens Aldehyde dehydrogenase family 3 member B1 Proteins 0.000 claims description 6
- 101000984916 Homo sapiens Butyrophilin subfamily 3 member A3 Proteins 0.000 claims description 6
- 101001065747 Homo sapiens E3 ubiquitin-protein ligase LRSAM1 Proteins 0.000 claims description 6
- 101000623216 Homo sapiens Endoribonuclease YbeY Proteins 0.000 claims description 6
- 101000814134 Homo sapiens Epithelial-stromal interaction protein 1 Proteins 0.000 claims description 6
- 101000745703 Homo sapiens Exportin-T Proteins 0.000 claims description 6
- 101000824117 Homo sapiens F-box only protein 30 Proteins 0.000 claims description 6
- 101000917536 Homo sapiens F-box only protein 7 Proteins 0.000 claims description 6
- 101001024249 Homo sapiens Guanine nucleotide-binding protein subunit beta-4 Proteins 0.000 claims description 6
- 101001045553 Homo sapiens Hemogen Proteins 0.000 claims description 6
- 101000838926 Homo sapiens Hermansky-Pudlak syndrome 1 protein Proteins 0.000 claims description 6
- 101000999373 Homo sapiens Interferon-related developmental regulator 2 Proteins 0.000 claims description 6
- 101000979145 Homo sapiens Macoilin Proteins 0.000 claims description 6
- 101000960626 Homo sapiens Mitochondrial inner membrane protease subunit 2 Proteins 0.000 claims description 6
- 101000595802 Homo sapiens Phospholipase A and acyltransferase 2 Proteins 0.000 claims description 6
- 101000772905 Homo sapiens Polyubiquitin-B Proteins 0.000 claims description 6
- 101001092185 Homo sapiens Regulator of cell cycle RGCC Proteins 0.000 claims description 6
- 101000700733 Homo sapiens Serine/arginine-rich splicing factor 8 Proteins 0.000 claims description 6
- 101000863882 Homo sapiens Sialic acid-binding Ig-like lectin 7 Proteins 0.000 claims description 6
- 101000933542 Homo sapiens Transcription factor BTF3 Proteins 0.000 claims description 6
- 101000663031 Homo sapiens Transmembrane and coiled-coil domains protein 1 Proteins 0.000 claims description 6
- 102100036480 Interferon-related developmental regulator 2 Human genes 0.000 claims description 6
- 102100023235 Macoilin Human genes 0.000 claims description 6
- 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 claims description 6
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 claims description 6
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 claims description 6
- 102100039840 Mitochondrial inner membrane protease subunit 2 Human genes 0.000 claims description 6
- 102100036067 Phospholipase A and acyltransferase 2 Human genes 0.000 claims description 6
- 102100030432 Polyubiquitin-B Human genes 0.000 claims description 6
- 102100035542 Regulator of cell cycle RGCC Human genes 0.000 claims description 6
- 108091006702 SLC24A4 Proteins 0.000 claims description 6
- 102100029289 Serine/arginine-rich splicing factor 8 Human genes 0.000 claims description 6
- 102100029946 Sialic acid-binding Ig-like lectin 7 Human genes 0.000 claims description 6
- 102100032003 Sodium/potassium/calcium exchanger 4 Human genes 0.000 claims description 6
- 101710113279 Solute carrier family 49 member A3 Proteins 0.000 claims description 6
- 102100021482 Solute carrier family 49 member A3 Human genes 0.000 claims description 6
- 102100037718 Transmembrane and coiled-coil domains protein 1 Human genes 0.000 claims description 6
- 108010035632 ornithine decarboxylase antizyme inhibitor Proteins 0.000 claims description 6
- 102100035473 2'-5'-oligoadenylate synthase-like protein Human genes 0.000 claims description 5
- 208000006820 Arthralgia Diseases 0.000 claims description 5
- 102100034808 CCAAT/enhancer-binding protein alpha Human genes 0.000 claims description 5
- 206010049047 Chapped lips Diseases 0.000 claims description 5
- 102100032396 Coiled-coil domain-containing protein 24 Human genes 0.000 claims description 5
- 102100025849 Complement C1q subcomponent subunit C Human genes 0.000 claims description 5
- 102100028572 Disabled homolog 2 Human genes 0.000 claims description 5
- 208000010201 Exanthema Diseases 0.000 claims description 5
- 102100040130 FH1/FH2 domain-containing protein 1 Human genes 0.000 claims description 5
- 101000597360 Homo sapiens 2'-5'-oligoadenylate synthase-like protein Proteins 0.000 claims description 5
- 101000610215 Homo sapiens Adenylyl-sulfate kinase Proteins 0.000 claims description 5
- 101000945515 Homo sapiens CCAAT/enhancer-binding protein alpha Proteins 0.000 claims description 5
- 101000868756 Homo sapiens Coiled-coil domain-containing protein 24 Proteins 0.000 claims description 5
- 101000933636 Homo sapiens Complement C1q subcomponent subunit C Proteins 0.000 claims description 5
- 101000915391 Homo sapiens Disabled homolog 2 Proteins 0.000 claims description 5
- 101000890761 Homo sapiens FH1/FH2 domain-containing protein 1 Proteins 0.000 claims description 5
- 101001120760 Homo sapiens Olfactomedin-4 Proteins 0.000 claims description 5
- 101001072881 Homo sapiens Phosphoglucomutase-like protein 5 Proteins 0.000 claims description 5
- 101000830710 Homo sapiens Torsin-4A Proteins 0.000 claims description 5
- 206010024570 Lip swelling Diseases 0.000 claims description 5
- 102100026071 Olfactomedin-4 Human genes 0.000 claims description 5
- 102100036635 Phosphoglucomutase-like protein 5 Human genes 0.000 claims description 5
- 206010037660 Pyrexia Diseases 0.000 claims description 5
- 102100024605 Torsin-4A Human genes 0.000 claims description 5
- 206010046851 Uveitis Diseases 0.000 claims description 5
- 206010047115 Vasculitis Diseases 0.000 claims description 5
- 208000006331 coronary aneurysm Diseases 0.000 claims description 5
- 231100000321 erythema Toxicity 0.000 claims description 5
- 201000005884 exanthem Diseases 0.000 claims description 5
- 210000004013 groin Anatomy 0.000 claims description 5
- 201000003265 lymphadenitis Diseases 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 206010037844 rash Diseases 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- 102100040529 CKLF-like MARVEL transmembrane domain-containing protein 4 Human genes 0.000 claims description 4
- 101000749431 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 4 Proteins 0.000 claims description 4
- 208000011200 Kawasaki disease Diseases 0.000 claims description 4
- 210000004904 fingernail bed Anatomy 0.000 claims description 4
- 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 claims description 4
- 201000005111 ocular hyperemia Diseases 0.000 claims description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 3
- 102100031351 Galectin-9 Human genes 0.000 claims description 3
- 102100033636 Histone H3.2 Human genes 0.000 claims description 3
- 101001130151 Homo sapiens Galectin-9 Proteins 0.000 claims description 3
- 101000871895 Homo sapiens Histone H3.2 Proteins 0.000 claims description 3
- 101000609261 Homo sapiens Plasminogen activator inhibitor 2 Proteins 0.000 claims description 3
- 101000814373 Homo sapiens Protein wntless homolog Proteins 0.000 claims description 3
- 101000759241 Homo sapiens Zinc finger protein 138 Proteins 0.000 claims description 3
- 102100039419 Plasminogen activator inhibitor 2 Human genes 0.000 claims description 3
- 102100039471 Protein wntless homolog Human genes 0.000 claims description 3
- 102100023394 Zinc finger protein 138 Human genes 0.000 claims description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 3
- 239000003246 corticosteroid Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 208000006740 Aseptic Meningitis Diseases 0.000 claims description 2
- 101001082584 Homo sapiens Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 Proteins 0.000 claims description 2
- 206010027201 Meningitis aseptic Diseases 0.000 claims description 2
- 102100030480 Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 Human genes 0.000 claims description 2
- 206010040844 Skin exfoliation Diseases 0.000 claims description 2
- 238000007899 nucleic acid hybridization Methods 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 238000003757 reverse transcription PCR Methods 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 102100030695 Electron transfer flavoprotein subunit alpha, mitochondrial Human genes 0.000 claims 3
- 101001010541 Homo sapiens Electron transfer flavoprotein subunit alpha, mitochondrial Proteins 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 101000617536 Homo sapiens Presenilin-1 Proteins 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 102100022033 Presenilin-1 Human genes 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 description 11
- 206010023232 Joint swelling Diseases 0.000 description 3
- 201000009906 Meningitis Diseases 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 108010054404 Adenylyl-sulfate kinase Proteins 0.000 description 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161581199P | 2011-12-29 | 2011-12-29 | |
| US61/581,199 | 2011-12-29 | ||
| PCT/US2012/071360 WO2013101758A1 (en) | 2011-12-29 | 2012-12-21 | Biomarkers for kawasaki disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015505245A JP2015505245A (ja) | 2015-02-19 |
| JP2015505245A5 true JP2015505245A5 (enExample) | 2016-02-12 |
Family
ID=47459205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014550413A Pending JP2015505245A (ja) | 2011-12-29 | 2012-12-21 | 川崎病のためのバイオマーカー |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20140348818A1 (enExample) |
| EP (1) | EP2798081A1 (enExample) |
| JP (1) | JP2015505245A (enExample) |
| KR (1) | KR20140108718A (enExample) |
| CN (1) | CN104160039B (enExample) |
| CA (1) | CA2862270A1 (enExample) |
| WO (1) | WO2013101758A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3137907A4 (en) * | 2014-05-02 | 2018-02-28 | Momenta Pharmaceuticals, Inc. | Methods and compositions for the diagnosis and treatment of kawasaki disease |
| CN104450901B (zh) * | 2014-11-27 | 2016-09-21 | 广州赛哲生物科技股份有限公司 | 快速诊断川崎病的核酸标记物及其试剂盒 |
| JP6153239B2 (ja) * | 2015-02-10 | 2017-06-28 | 公立大学法人横浜市立大学 | 川崎病の検査方法およびキット |
| CN105112552B (zh) * | 2015-09-28 | 2018-02-27 | 北京泱深生物信息技术有限公司 | Ift52基因在骨质疏松症诊断中的应用 |
| JP7132233B2 (ja) * | 2016-11-11 | 2022-09-06 | アセンダント ディーエックス， エルエルシー | 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法 |
| CN106636413B (zh) * | 2016-12-28 | 2019-07-16 | 常州市第二人民医院 | 一种用于诊断哮喘的分子标志物 |
| CN106701962B (zh) * | 2016-12-28 | 2020-07-28 | 广州赛哲生物科技股份有限公司 | 用于川崎病检测的引物组、探针及试剂盒 |
| CN110824173B (zh) * | 2019-11-27 | 2022-09-02 | 中国人民解放军陆军军医大学第一附属医院 | 促血管生成因子pdgfc在作为诊断和治疗肝肺综合征的标志物中的应用 |
| WO2025077406A1 (zh) * | 2023-10-11 | 2025-04-17 | 中国医学科学院北京协和医院 | 一种新生物标志物在诊断或辅助诊断spn中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US7192584B2 (en) * | 1991-03-18 | 2007-03-20 | Centocor, Inc. | Methods of treating psoriasis with anti-TNF antibodies |
| US5286623A (en) * | 1991-11-26 | 1994-02-15 | National Jewish Center For Immunology And Respiratory Medicine | Method for screening for Kawasaki disease |
| US5279721A (en) | 1993-04-22 | 1994-01-18 | Peter Schmid | Apparatus and method for an automated electrophoresis system |
| ATE507240T1 (de) * | 2004-03-05 | 2011-05-15 | Vegenics Pty Ltd | Materialien und verfahren für wachstumsfaktorbindende konstrukte |
| SG157299A1 (en) * | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| WO2010025393A2 (en) | 2008-08-28 | 2010-03-04 | The Regents Of The University Of California | Protein biomarkers and methods for diagnosing kawasaki disease |
| CA2766403A1 (en) * | 2009-07-13 | 2011-01-20 | Genentech, Inc. | Diagnostic methods and compositions for treatment of cancer |
-
2012
- 2012-12-21 KR KR1020147021229A patent/KR20140108718A/ko not_active Withdrawn
- 2012-12-21 WO PCT/US2012/071360 patent/WO2013101758A1/en not_active Ceased
- 2012-12-21 US US14/362,857 patent/US20140348818A1/en not_active Abandoned
- 2012-12-21 EP EP12808661.8A patent/EP2798081A1/en not_active Withdrawn
- 2012-12-21 CA CA2862270A patent/CA2862270A1/en not_active Abandoned
- 2012-12-21 CN CN201280070975.0A patent/CN104160039B/zh active Active
- 2012-12-21 JP JP2014550413A patent/JP2015505245A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015505245A5 (enExample) | ||
| Johnson et al. | Pulmonary hypertension: a contemporary review | |
| Maher et al. | Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis | |
| Bible et al. | Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study | |
| Farber et al. | Five-year outcomes of patients enrolled in the REVEAL Registry | |
| Charo et al. | Anti-inflammatory therapeutics for the treatment of atherosclerosis | |
| Vorselaars et al. | Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis | |
| Lange et al. | Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events | |
| Alnasser et al. | Late consequences of acute coronary syndromes: global registry of acute coronary events (GRACE) follow-up | |
| Hong et al. | Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation–related mild ischemic stroke: a randomized clinical trial | |
| Sterling et al. | The effect of liver disease on lactate normalization in severe sepsis and septic shock: a cohort study | |
| Yoshida et al. | Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients | |
| Durheim et al. | Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group | |
| Kovacs et al. | Characterization of patients with borderline pulmonary arterial pressure | |
| Ferder et al. | Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy | |
| JP2017518283A5 (enExample) | ||
| Chou et al. | Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS). | |
| Shaya et al. | High exercise capacity attenuates the risk of early mortality after a first myocardial infarction: the Henry Ford Exercise Testing (FIT) Project | |
| Feenstra et al. | Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index | |
| Hori et al. | Myocardial ischemic reduction evidenced by gated myocardial perfusion imaging after treatment results in good prognosis in patients with coronary artery disease | |
| Kim et al. | Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study | |
| Calandra-Buonaura et al. | Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson’s disease | |
| Lally et al. | Personalised approaches to pharmacotherapy for schizophrenia | |
| Chang et al. | Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people | |
| Vemulapalli et al. | Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial) |